Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Affinity Capital Management offers investment services to firms in the healthcare technology industry. It was founded in 1993 by Edson Spencer and is based in Minnesota.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2012 | Sonitus Medical | Series D | 25M |
12/2004 | Transneuronix | Series B | 16.7M |
5/2007 | Pegasus Biologics | Series C | 20M |
12/2004 | Myocor | Series D | 24M |
9/2001 | NOVASYS MEDICAL | Series B | 13M |
8/2010 | Respicardia | Series C | 0 |
5/2006 | Uptake Medical | Series A | 9M |
8/2000 | Ican | Venture Round | 4M |
8/2000 | Ican | Venture Round | 4M |
2/2009 | Primaeva Medical | Series C | 6M |
3/2007 | Transoma Medical | Series C | 13M |
3/2012 | Uptake Medical | Series C | 40.3M |
5/2004 | Disc Dynamics | Series E | 24M |
9/2007 | Atritech | Series D | 22M |
2/2000 | Agiliti | Series B | 0 |
1/2011 | Celleration | Series E | 0 |
4/2019 | ExplORer Surgical | Series A | 0 |
4/2008 | CoAxia | Series C | 11.5M |
7/2002 | Celleration | Series B | 0 |
11/2002 | Alliance Medical Corporation | Series E | 7.3M |
9/2006 | CoAxia | Series C | 11M |
7/2010 | Uptake Medical | Series B | 17.5M |
5/2009 | iScience Interventional | Series F | 20.5M |
9/2009 | ValenTx | Series B | 0 |
1/2008 | Arbor Surgical Technologies | Series C | 0 |
5/2007 | Pegasus Biologics | Series C | 20M |
4/2004 | NOVASYS MEDICAL | Series C | 25M |
6/2010 | Anulex Technologies | Series E | 18.3M |
1/2012 | iScience Interventional | Venture Round | 2.8M |
4/2010 | Hemosphere | Series A | 9.3M |
12/2006 | Respicardia | Series A | 5.5M |
3/2006 | Atritech | Series C | 22.5M |
6/2009 | CoAxia | Series D | 21.5M |
7/2006 | Anulex Technologies | Series C | 20M |
6/2010 | Baxano | Series C | 30M |
10/2005 | Transoma Medical | Series B | 12.7M |
5/2009 | Anulex Technologies | Series D | 10.2M |
10/2008 | Respicardia | Series B | 0 |
8/2008 | Spineology | Series B | 1.5M |
9/2013 | Respicardia | Series D | 10M |
5/2008 | Novasys Health | Venture Round | 49.5M |
9/2008 | Transoma Medical | Series D | 5M |
5/2008 | Novasys Medical, Inc. | Series D | 49.5M |
4/2019 | ExplORer Surgical | Series A | 0 |
9/2013 | Respicardia | Series D | 0 |
5/2012 | Sonitus Medical | Series D | 0 |
3/2012 | Uptake Medical | Series C | 0 |
1/2012 | iScience Interventional | Venture Round | 0 |
1/2011 | Celleration | Series E | 0 |
8/2010 | Respicardia | Series C | 0 |
7/2010 | Uptake Medical | Series B | 0 |
6/2010 | Baxano | Series C | 0 |
6/2010 | Anulex Technologies | Series E | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|